Additionally, by modulating BMP-1 activity, the immune system’s response to gout inflammation can be optimized, achieving a balance between pro-inflammatory and anti-inflammatory effects, thus offering comprehensive treatment benefits to patients with gout.However, the development of therapeutic strategies targeting BMP-1 also faces challenges. This evidence concerns the gene BMP1 and gout.